Thomas J. Fuchs
Ph.D.
Dean of AI and Human Health; Co-founder, Paige.AI
👥Biography 个人简介
Thomas Fuchs is a pioneer in computational pathology who developed the first FDA-approved AI system for cancer diagnosis (Paige Prostate). His work at Memorial Sloan Kettering and Mount Sinai has established deep learning methods for analyzing pathology images at scale. Fuchs co-founded Paige.AI to translate these innovations into clinical practice, revolutionizing how pathologists diagnose cancer.
Thomas Fuchs是计算病理学的先驱,开发了首个FDA批准的癌症诊断AI系统(Paige Prostate)。他在纪念斯隆-凯特琳和西奈山的工作建立了大规模分析病理图像的深度学习方法。Fuchs联合创立了Paige.AI,将这些创新转化为临床实践,彻底改变了病理学家诊断癌症的方式。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
FDA-Approved AI
Developed first FDA-approved AI for pathology (Paige Prostate for prostate cancer detection).
Clinical AI Deployment
Pioneered deployment of AI pathology systems in clinical workflows.
Representative Works 代表性著作
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
Nature Medicine (2019)
Multiple instance learning framework for clinical pathology AI.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
关注 Thomas J. Fuchs 的研究动态
Follow Thomas J. Fuchs's research updates
留下邮箱,当我们发布与 Thomas J. Fuchs(Mount Sinai / Paige.AI)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment